Profile | GDS5420 / 231987_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 232.78 | 55 |
GSM1296119 | B_lesional_pre-dose | 423.84 | 65 |
GSM1296076 | C_lesional_pre-dose | 181.6 | 52 |
GSM1296092 | D_lesional_pre-dose | 66.52 | 38 |
GSM1296103 | E_lesional_pre-dose | 198.37 | 52 |
GSM1296078 | F_lesional_pre-dose | 186.17 | 53 |
GSM1296107 | G_lesional_pre-dose | 602.92 | 71 |
GSM1296109 | H_lesional_pre-dose | 466.29 | 66 |
GSM1296080 | I_lesional_pre-dose | 300.07 | 60 |
GSM1296090 | J_lesional_pre-dose | 113.95 | 45 |
GSM1296074 | K_lesional_pre-dose | 91.22 | 43 |
GSM1296111 | L_lesional_pre-dose | 530.81 | 69 |
GSM1296099 | M_lesional_pre-dose | 255.73 | 56 |
GSM1296086 | O_lesional_pre-dose | 204.29 | 54 |
GSM1296117 | P_lesional_pre-dose | 363.67 | 62 |
GSM1296113 | Q_lesional_pre-dose | 546.55 | 69 |
GSM1296096 | R_lesional_pre-dose | 241.49 | 56 |
GSM1296105 | S_lesional_pre-dose | 1389.13 | 84 |
GSM1296098 | T_lesional_pre-dose | 122.05 | 44 |
GSM1296101 | U_lesional_pre-dose | 236.79 | 55 |
GSM1296121 | V_lesional_pre-dose | 501.33 | 68 |
GSM1296088 | W_lesional_pre-dose | 246.55 | 56 |
GSM1296082 | X_lesional_pre-dose | 115.58 | 45 |
GSM1296115 | Y_lesional_pre-dose | 398.11 | 64 |
GSM1296084 | Z_lesional_pre-dose | 389.13 | 64 |
GSM1296072 | B_lesional_day8 | 427.15 | 65 |
GSM1296069 | L_lesional_day8 | 877.06 | 77 |
GSM1296071 | P_lesional_day8 | 1309.04 | 84 |
GSM1296070 | Y_lesional_day8 | 749.3 | 75 |
GSM1296073 | V_lesional_day8 | 227.73 | 55 |
GSM1296034 | A_lesional_day15 | 452.65 | 65 |
GSM1296041 | G_lesional_day15 | 242.89 | 55 |
GSM1296035 | R_lesional_day15 | 151.4 | 48 |
GSM1296038 | U_lesional_day15 | 214.43 | 54 |
GSM1296047 | B_lesional_day15 | 694.45 | 73 |
GSM1296039 | E_lesional_day15 | 116.9 | 44 |
GSM1296042 | H_lesional_day15 | 521.65 | 68 |
GSM1296043 | L_lesional_day15 | 1054.29 | 80 |
GSM1296037 | M_lesional_day15 | 436.64 | 65 |
GSM1296046 | P_lesional_day15 | 797.89 | 76 |
GSM1296044 | Q_lesional_day15 | 517.49 | 68 |
GSM1296045 | Y_lesional_day15 | 629.02 | 71 |
GSM1296025 | C_lesional_day15 | 549.67 | 69 |
GSM1296033 | D_lesional_day15 | 210.88 | 53 |
GSM1296027 | I_lesional_day15 | 345.55 | 62 |
GSM1296032 | J_lesional_day15 | 285.74 | 58 |
GSM1296024 | K_lesional_day15 | 540.66 | 69 |
GSM1296031 | W_lesional_day15 | 532.23 | 68 |
GSM1296028 | X_lesional_day15 | 672.91 | 72 |
GSM1296029 | Z_lesional_day15 | 460.41 | 66 |
GSM1296026 | F_lesional_day15 | 461.05 | 67 |
GSM1296030 | O_lesional_day15 | 128.19 | 48 |
GSM1296040 | S_lesional_day15 | 624.83 | 71 |
GSM1296036 | T_lesional_day15 | 215.82 | 53 |
GSM1296048 | V_lesional_day15 | 321.75 | 60 |
GSM1296059 | A_lesional_day43 | 127.68 | 46 |
GSM1296066 | G_lesional_day43 | 533.67 | 69 |
GSM1296060 | R_lesional_day43 | 210.19 | 53 |
GSM1296063 | U_lesional_day43 | 186.24 | 51 |
GSM1296064 | E_lesional_day43 | 119.97 | 45 |
GSM1296067 | H_lesional_day43 | 1305.4 | 84 |
GSM1296062 | M_lesional_day43 | 449.95 | 65 |
GSM1296068 | Q_lesional_day43 | 950.52 | 79 |
GSM1296050 | C_lesional_day43 | 715.85 | 74 |
GSM1296057 | D_lesional_day43 | 499.58 | 67 |
GSM1296052 | I_lesional_day43 | 306.86 | 60 |
GSM1296054 | J_lesional_day43 | 244.41 | 55 |
GSM1296049 | K_lesional_day43 | 341.32 | 61 |
GSM1296055 | W_lesional_day43 | 699.66 | 73 |
GSM1296053 | X_lesional_day43 | 462.28 | 66 |
GSM1296058 | Z_lesional_day43 | 276.25 | 58 |
GSM1296051 | F_lesional_day43 | 318.86 | 61 |
GSM1296056 | O_lesional_day43 | 171.91 | 51 |
GSM1296065 | S_lesional_day43 | 543.43 | 69 |
GSM1296061 | T_lesional_day43 | 245.71 | 55 |
GSM1296095 | A_non-lesional_pre-dose | 184.41 | 51 |
GSM1296120 | B_non-lesional_pre-dose | 656.44 | 72 |
GSM1296077 | C_non-lesional_pre-dose | 328.35 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 420.02 | 64 |
GSM1296104 | E_non-lesional_pre-dose | 258.17 | 56 |
GSM1296079 | F_non-lesional_pre-dose | 722.12 | 74 |
GSM1296108 | G_non-lesional_pre-dose | 766.87 | 75 |
GSM1296110 | H_non-lesional_pre-dose | 659.04 | 72 |
GSM1296081 | I_non-lesional_pre-dose | 595.1 | 71 |
GSM1296091 | J_non-lesional_pre-dose | 222.59 | 55 |
GSM1296075 | K_non-lesional_pre-dose | 172.27 | 51 |
GSM1296112 | L_non-lesional_pre-dose | 1453.14 | 86 |
GSM1296100 | M_non-lesional_pre-dose | 1062.39 | 80 |
GSM1296087 | O_non-lesional_pre-dose | 207.81 | 55 |
GSM1296118 | P_non-lesional_pre-dose | 1050.52 | 80 |
GSM1296114 | Q_non-lesional_pre-dose | 515.79 | 68 |
GSM1296097 | R_non-lesional_pre-dose | 314.82 | 60 |
GSM1296106 | S_non-lesional_pre-dose | 666.44 | 72 |
GSM1296102 | U_non-lesional_pre-dose | 396.39 | 63 |
GSM1296122 | V_non-lesional_pre-dose | 1430.48 | 85 |
GSM1296089 | W_non-lesional_pre-dose | 634.89 | 71 |
GSM1296083 | X_non-lesional_pre-dose | 982.04 | 79 |
GSM1296116 | Y_non-lesional_pre-dose | 1024.37 | 80 |
GSM1296085 | Z_non-lesional_pre-dose | 477.74 | 67 |